Sunday 27 September 2020
Home      All news      Contact us      RSS      India
news18 - 18 days ago

CanSino Phase 3 COVID-19 Vaccine Trial In Pakistan Expected To Begin This Month

Falling COVID19 infection numbers in Pakistan will not affect a Phase 3 clinical trial for a potential vaccine being developed by China s CanSino Biologics, which is expected to begin this month, according to officials running the trial.


Latest News
Hashtags:   

CanSino

 | 

Phase

 | 

COVID

 | 

Vaccine

 | 

Trial

 | 

Pakistan

 | 

Expected

 | 

Begin

 | 

Month

 | 

Sources